SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-20-250342
Filing Date
2020-09-22
Accepted
2020-09-21 18:17:29
Documents
5
Period of Report
2020-09-21

Document Format Files

Seq Description Document Type Size
1 6-K d70192d6k.htm 6-K 11528
2 EX-99.1 d70192dex991.htm EX-99.1 56432
3 EX-99.2 d70192dex992.htm EX-99.2 24773
4 GRAPHIC g70192g57b65.jpg GRAPHIC 5152
5 GRAPHIC g70192g64h41.jpg GRAPHIC 4804
  Complete submission text file 0001193125-20-250342.txt   107878
Mailing Address 60 AVENUE ROCKEFELLER BATIMENT ADENINE LYON I0 69008
Business Address 60 AVENUE ROCKEFELLER BATIMENT ADENINE LYON I0 69008 011-33-4-78-74-44-38
Erytech Pharma S.A. (Filer) CIK: 0001624422 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38281 | Film No.: 201187415
SIC: 2836 Biological Products, (No Diagnostic Substances)